Silver Book Fact

An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.

Toth C, Mawani S, Brady S, Chan C, et al. An Enriched-Enrollment, Randomized Withdrawal, Flexible-Dose, Double-Blind, Placebo-Controlled, Parallel Assignment Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain. Pain. 2012; 153(10): 2073-82. http://journals.lww.com/pain/Abstract/2012/10000/An_enriched_enrolment,_randomized_withdrawal,.16.aspx

Reference

Title
An Enriched-Enrollment, Randomized Withdrawal, Flexible-Dose, Double-Blind, Placebo-Controlled, Parallel Assignment Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain
Publication
Pain
Publication Date
2012
Authors
Toth C, Mawani S, Brady S, Chan C, et al
Volume & Issue
Volume 153, Issue 10
Pages
2073-82
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The combination of information for neuroimaging and circulatory biomarkers could improve both the sensitivity and specificity of pain diagnosis and thereby improve treatment.  
  • People with persistent pain who used complementary and alternative medicine (CAM) had lower average health care expenditures than nonusers ($3,797 versus $4,153).  
  • Opioids have been found to reduce pain intensity and improve physical functioning for patients with persistent noncancer pain. It’s important to note that a decrease in mental health functioning…  
  • An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.  
  • Advances in neuroimaging will continue to offer information on the brain’s functioning and how it correlates to the pain experience.